Clinical and bacteriologic efficacy of ceftriaxone in the United States.

Author: McCloskeyR V

Paper Details 
Original Abstract of the Article :
The clinical and bacteriologic efficacy of ceftriaxone given once or twice daily was evaluated in 153 studies. A total of 2,635 patients received ceftriaxone given intramuscularly or intravenously, 930 received comparative antibiotics, and 81 received placebo. For the 10 major categories of infectio...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/6093528

データ提供:米国国立医学図書館(NLM)

Clinical and Bacteriologic Efficacy of Ceftriaxone in the United States

This study examines the effectiveness of ceftriaxone, a widely used antibiotic, in treating a variety of bacterial infections. The researchers compiled data from numerous clinical trials to assess ceftriaxone's efficacy in different types of infections, ranging from respiratory infections to skin infections.

Ceftriaxone's Effectiveness Against Bacterial Infections

The study revealed that ceftriaxone was highly effective in treating a wide range of bacterial infections. The results demonstrate ceftriaxone's robust ability to fight bacteria and its potential to be a valuable treatment option for a variety of infections.

Ceftriaxone's Role in Infection Management

This study underscores the importance of antibiotics in fighting bacterial infections. It's crucial to remember that antibiotics should only be used when prescribed by a doctor, and the full course of treatment should be completed to ensure the infection is fully eradicated.

Dr.Camel's Conclusion

Ceftriaxone is like a mighty camel trekking across the desert, fighting off the challenges of bacterial infections. It's a valuable tool in the fight against infection, but like any powerful tool, it should be used wisely and responsibly.

Date :
  1. Date Completed 1984-12-05
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

6093528

DOI: Digital Object Identifier

6093528

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.